LONDON - Women entering menopause should not worry about hormone replacement therapy — despite a highly publicized study that put off many woman from the drugs, an international panel of experts said on Tuesday.
Researchers told a global menopause summit in Madrid that a 2002 study which discouraged many women from hormone replacement therapy (HRT) was flawed, as the subject group was relatively old and suffered from other conditions that all boosted risk.
Amos Pines, chairman of the International Menopause Society, said his team had reviewed dozens of published studies and found no increase in the risk of heart disease in women aged 50 to 59.